OpenURL Connection Search

Select item for more details and to access through your institution.

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.
Published in:
EMBO Molecular Medicine, 2013, v. 5, n. 8, p. 1180, doi. 10.1002/emmm.201202034
By:
- Emadali, Anouk;
- Rousseaux, Sophie;
- Bruder‐Costa, Juliana;
- Rome, Claire;
- Duley, Samuel;
- Hamaidia, Sieme;
- Betton, Patricia;
- Debernardi, Alexandra;
- Leroux, Dominique;
- Bernay, Benoit;
- Kieffer‐Jaquinod, Sylvie;
- Combes, Florence;
- Ferri, Elena;
- McKenna, Charles E.;
- Petosa, Carlo;
- Bruley, Christophe;
- Garin, Jérôme;
- Ferro, Myriam;
- Gressin, Rémy;
- Callanan, Mary B.
Publication type:
Article
Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer.
Published in:
Cancers, 2023, v. 15, n. 1, p. 158, doi. 10.3390/cancers15010158
By:
- Tournier, Benjamin;
- Aucagne, Romain;
- Truntzer, Caroline;
- Fournier, Cyril;
- Ghiringhelli, François;
- Chapusot, Caroline;
- Martin, Laurent;
- Bouvier, Anne Marie;
- Manfredi, Sylvain;
- Jooste, Valérie;
- Callanan, Mary B.;
- Lepage, Côme
Publication type:
Article
c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma.
Published in:
Journal of Pathology: Clinical Research, 2021, v. 7, n. 6, p. 604, doi. 10.1002/cjp2.223
By:
- Bouroumeau, Antonin;
- Bussot, Lucile;
- Bonnefoix, Thierry;
- Fournier, Cyril;
- Chapusot, Caroline;
- Casasnovas, Olivier;
- Martin, Laurent;
- McLeer, Anne;
- Col, Edwige;
- David‐Boudet, Laurence;
- Lefebvre, Christine;
- Algrin, Caroline;
- Raskovalova, Tatiana;
- Jacob, Marie‐Christine;
- Vettier, Claire;
- Chevalier, Simon;
- Callanan, Mary B;
- Gressin, Rémy;
- Emadali, Anouk;
- Sartelet, Hervé
Publication type:
Article
Repeat Element Activation-Driven Inflammation: Role of NFκB and Implications in Normal Development and Cancer?
Published in:
Biomedicines, 2022, v. 10, n. 12, p. 3101, doi. 10.3390/biomedicines10123101
By:
- Dumetier, Baptiste;
- Sauter, Camille;
- Hajmirza, Azadeh;
- Pernon, Baptiste;
- Aucagne, Romain;
- Fournier, Cyril;
- Row, Céline;
- Guidez, Fabien;
- Rossi, Cédric;
- Lepage, Côme;
- Delva, Laurent;
- Callanan, Mary B.
Publication type:
Article
BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer.
Published in:
Biomedicines, 2018, v. 6, n. 1, p. 16, doi. 10.3390/biomedicines6010016
By:
- Hajmirza, Azadeh;
- Emadali, Anouk;
- Gauthier, Arnaud;
- Casasnovas, Olivier;
- Gressin, Rémy;
- Callanan, Mary B.
Publication type:
Article
Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.
Published in:
British Journal of Haematology, 2012, v. 158, n. 2, p. 186, doi. 10.1111/j.1365-2141.2012.09161.x
By:
- Gimenez, Estelle;
- Chauvet, Martine;
- Rabin, Laetitia;
- Puteaud, Isabelle;
- Duley, Samuel;
- Hamaidia, Sieme;
- Bruder, Juliana;
- Rolland-Neyret, Valérie;
- Gouill, Steven;
- Tournilhac, Olivier;
- Voog, Eric;
- Maisonneuve, Hervé;
- Jacob, Marie C.;
- Leroux, Dominique;
- Béné, Marie C.;
- Formisano-Tréziny, Christine;
- Gabert, Jean;
- Gressin, Rémy;
- Callanan, Mary B.
Publication type:
Article

Found: 6

Identification of a novel BET bromodomain inhibitor-sensitive, gene regulatory circuit that controls Rituximab response and tumour growth in aggressive lymphoid cancers.

Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer.

c‐MYC and p53 expression highlight starry‐sky pattern as a favourable prognostic feature in R‐CHOP‐treated diffuse large B‐cell lymphoma.

Repeat Element Activation-Driven Inflammation: Role of NFκB and Implications in Normal Development and Cancer?

BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer.

Cloned IGH VDJ targets as tools for personalized minimal residual disease monitoring in mature lymphoid malignancies; a feasibility study in mantle cell lymphoma by the Groupe Ouest Est d'Etude des Leucémies et Autres Maladies du Sang.